Log in to save to my catalogue

Anti-Cancer Immunotherapies Targeting Telomerase

Anti-Cancer Immunotherapies Targeting Telomerase

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465444

Anti-Cancer Immunotherapies Targeting Telomerase

About this item

Full title

Anti-Cancer Immunotherapies Targeting Telomerase

Publisher

MDPI

Journal title

Cancers, 2020-08, Vol.12 (8), p.2260

Language

English

Formats

Publication information

Publisher

MDPI

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Telomerase is a reverse transcriptase that maintains telomeres length, compensating for the attrition of chromosomal ends that occurs during each replication cycle. Telomerase is expressed in germ cells and stem cells, whereas it is virtually undetectable in adult somatic cells. On the other hand, telomerase is broadly expressed in the majority of...

Alternative Titles

Full title

Anti-Cancer Immunotherapies Targeting Telomerase

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465444

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465444

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers12082260

How to access this item